The UK government has formally opened a state-of-the-art vaccine research facility based at the UK Health and Security Agency (UKHSA) to improve the country's preparedness
A team at GSK has identified what could be an entirely new weapon in the fight to eradicate malaria – but it isn't a new vaccine or antimalarial compound.
After months of deliberations, the National Institute of Allergy and Infectious Diseases (NIAID) has a new director to replace Dr Anthony Fauci, who held the role for 38 y
GSK has filed a lawsuit against Pfizer in a US court alleging infringement of patents that it holds on vaccines against respiratory syncytial virus (RSV).
More than 1.5 billion people around the world are infected with soil-transmitted helminths (STHs), parasitic worms that damage their health and are a leading cause of maln
The yearly subscription-style payments made by NHS England to developers of novel antibiotics could be doubled from £10 million to £20 million in some cases, according to
A pharma company’s core mission is to improve patient outcomes. This hinges on effectively influencing HCP clinical behaviour and driving disease education.